Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D03RAU
|
|||
Drug Name |
Pyrimidinone derivative 5
|
|||
Synonyms |
PMID28447479-Compound-6
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Structure |
Download2D MOL |
|||
Formula |
C21H26ClN3O4
|
|||
Canonical SMILES |
CCCCCC1=NC(=CC(=O)N1CC(=O)NCCCC(=O)O)C2=CC=C(C=C2)Cl
|
|||
InChI |
1S/C21H26ClN3O4/c1-2-3-4-6-18-24-17(15-8-10-16(22)11-9-15)13-20(27)25(18)14-19(26)23-12-5-7-21(28)29/h8-11,13H,2-7,12,14H2,1H3,(H,23,26)(H,28,29)
|
|||
InChIKey |
GMCBZWCKSMXZFV-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Extracellular lysophospholipase D (E-NPP2) | Target Info | Inhibitor | [1] |
Target's Patent Info | Extracellular lysophospholipase D (E-NPP2) | Target's Patent Info | [1] | |
KEGG Pathway | Ether lipid metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | Autotaxin inhibitors: a patent review (2012-2016).Expert Opin Ther Pat. 2017 Jul;27(7):815-829. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.